1. Home
  2. BLX vs PGEN Comparison

BLX vs PGEN Comparison

Compare BLX & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Latinoamericano de Comercio Exterior S.A.

BLX

Banco Latinoamericano de Comercio Exterior S.A.

HOLD

Current Price

$50.26

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.58

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLX
PGEN
Founded
1977
1998
Country
Panama
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
BLX
PGEN
Price
$50.26
$3.58
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.67
AVG Volume (30 Days)
115.7K
4.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
5.50%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$13.11
$342.78
Revenue Next Year
$10.13
$478.46
P/E Ratio
$8.26
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.14
$1.11
52 Week High
$51.99
$5.47

Technical Indicators

Market Signals
Indicator
BLX
PGEN
Relative Strength Index (RSI) 57.79 33.80
Support Level $43.50 $3.49
Resistance Level $51.99 $5.10
Average True Range (ATR) 1.33 0.36
MACD -0.12 -0.13
Stochastic Oscillator 52.73 1.57

Price Performance

Historical Comparison
BLX
PGEN

About BLX Banco Latinoamericano de Comercio Exterior S.A.

Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: